RECTAL CANCER, ADENOCARCINOMA
Clinical trials for RECTAL CANCER, ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER, ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL CANCER, ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost for rectal cancer treatment?
Disease control Recruiting nowThis study is testing if adding a specific probiotic supplement (Probio-M9) to a standard treatment plan improves results for people with locally advanced rectal cancer. All participants will receive chemotherapy, radiation, and an immunotherapy drug (tislelizumab). Researchers w…
Matched conditions: RECTAL CANCER, ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Seventh Medical Center of PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New approach aims to shrink rectal tumors before surgery, potentially avoiding immediate operation
Disease control Recruiting nowThis study is testing a comprehensive treatment approach for people with high-risk rectal cancer that hasn't spread to distant organs. All participants will receive one week of radiation followed by six cycles of combined chemotherapy and immunotherapy before surgery. The goal is…
Matched conditions: RECTAL CANCER, ADENOCARCINOMA
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Triple-Threat attack on Tough-to-Treat colon cancer
Disease control Recruiting nowThis study is testing a new first-line treatment for people with advanced, HER2-positive colorectal cancer that cannot be removed by surgery. It combines three drugs—trastuzumab-deruxtecan, capecitabine, and bevacizumab—to see how well they shrink tumors and control the disease. …
Matched conditions: RECTAL CANCER, ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC